Article Text

PDF
FRI0131 The 2010 acr/eular criteria are insufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: results from the leiden-eac and espoir cohorts
  1. D Boeters1,
  2. C Gaujoux-Viala2,
  3. A Constantin3,
  4. A van der Helm-van Mil1
  1. 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands
  2. 2Department of Rheumatology, Nîmes University Hospital; EA2415, Montpellier University, Nîmes
  3. 3Department of Rheumatology, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, Toulouse, France

Abstract

Background The 2010-ACR/EULAR criteria were derived to classify RA earlier in time. Previous studies indeed observed that the 2010-criteria were fulfilled earlier than the 1987-criteria. This study determined whether the 2010-criteria perform equally in the early detection of autoantibody-positive and autoantibody-negative RA.

Objectives To compare the performance of the 2010-criteria between autoantibody-positive and autoantibody-negative RA within two different early arthritis cohorts.

Methods From the total Leiden-EAC (n=3448) and ESPOIR (n=813) RA-patients who fulfilled the 1987-RA criteria at 1-year but not at presentation were selected (n=515 and n=53, respectively). These RA-patients were studied on the presence of ACPA and RF, and on fulfilling the 2010-criteria at baseline, as 2010-positivity indicated that these RA-patients were earlier identified.

Results In the EAC, 67% of the selected RA-patients did already fulfil the 2010-criteria at baseline. In ESPOIR this was 57%, indeed demonstrating early classification with the 2010-criteria. Among the selected autoantibody-positive RA-patients of the EAC, 85% was identified at baseline already with the 2010-criteria. Within autoantibody-negative RA this was 45% (p<0.001). Similarly within autoantibody-positive RA-patients in ESPOIR 92% was 2010-positive at baseline, whereas this was only 25% within autoantibody-negative RA (p<0.001).

Conclusions The 2010-criteria perform well in the early identification of autoantibody-positive RA, but autoantibody-negative RA-patients are still frequently missed with these criteria. As it has been demonstrated that early treatment initiation is beneficial for the outcome of ACPA-negative RA as well, other diagnostics are required for the early identification of ACPA-negative RA.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.